✉: [email protected]📞: +91 120 478 1209
ae5c6bd4 drug design discovery scaled

Research & Reviews: A Journal of Drug Design & Discovery

2349-9036 Peer‑Reviewed | Subscription‑Based

rrjoddd Volume: 13, Issue: 01 Year: 2026

5

Regular Issue  Subscription Review Article Published on :- Nov 16, 2025
By  

 

Chandani B. Patil, Jagruti G. Khairnar, Sunila A. Patil, Sunil P. Pawar,
Abstract : A complicated, multidisciplinary, and resource-intensive process, the discovery and development of new pharmacological drugs is essential to the read more

[This section belongs to Research & Reviews: A Journal of Drug Design & Discovery (rrjoddd)]

 

 

01-04
Regular Issue  Subscription Review Article Published on :- Dec 15, 2025
By  

 

Khalid M. Darwish, Ehab El-Hawary,
Abstract : Inflammation diseases still threaten humanity everywhere. For which there is always a continuous demand for immediate medication, the so-called read more

[This section belongs to Research & Reviews: A Journal of Drug Design & Discovery (rrjoddd)]

 

 

05-18
Regular Issue  Subscription Review Article Published on :- Nov 23, 2025
By  

 

Parmar Harshul, Varma Vishnu, Shubham Singh,
Abstract : The integration of nanomedicine and tissue engineering offers transformative strategies for cancer therapy by directly modulating the physiological read more

[This section belongs to Research & Reviews: A Journal of Drug Design & Discovery (rrjoddd)]

 

 

19-31
Regular Issue  Subscription Review Article Published on :- Nov 30, 2025
By  

 

Sneha Sanjay Pawar, Nandani panda, Isha bachhave, Bhupendra M. Mahale,
Abstract : The process of finding new leads for medicines using natural products is challenging. It discusses bioactive composites generated from natural read more

[This section belongs to Research & Reviews: A Journal of Drug Design & Discovery (rrjoddd)]

 

 

32-48
Regular Issue  Subscription Review Article Published on :- Nov 23, 2025
By  

 

Isha Sunil,
Abstract : Multidrug-resistant TB is a growing worldwide health concern, particularly in high-burden areas. Resistance to frontline drugs like isoniazid and read more

[This section belongs to Research & Reviews: A Journal of Drug Design & Discovery (rrjoddd)]

 

 

49-63

Editorial Board

View Full Editorial Board

rrjoddd maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Editor in Chief

Editor

Dr. Sidhartha Sankar Kar, Professor & HOD

School of Pharmacy, DRIEMS University, Cuttack, Odisha, India, 754022

Email :